In previous studies, researchers used all-trans retinoic acid (ATRA) to treat different lung cancer cells and found that the most significant reduction in the transcription level of SLC2A1 was found in SLC2A1 and the genes in the same family, thus excluding other gene families [5]. The gene discussed is SLC2A1; the disease is lung cancer.